M.R. BARNARD

2.8k total citations
30 papers, 2.2k citations indexed

About

M.R. BARNARD is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Internal Medicine. According to data from OpenAlex, M.R. BARNARD has authored 30 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 15 papers in Cardiology and Cardiovascular Medicine and 8 papers in Internal Medicine. Recurrent topics in M.R. BARNARD's work include Platelet Disorders and Treatments (19 papers), Antiplatelet Therapy and Cardiovascular Diseases (12 papers) and Venous Thromboembolism Diagnosis and Management (8 papers). M.R. BARNARD is often cited by papers focused on Platelet Disorders and Treatments (19 papers), Antiplatelet Therapy and Cardiovascular Diseases (12 papers) and Venous Thromboembolism Diagnosis and Management (8 papers). M.R. BARNARD collaborates with scholars based in United States, United Kingdom and Taiwan. M.R. BARNARD's co-authors include Alan D. Michelson, Joseph Loscalzo, C. R. Valeri, Hollace MacGregor, A D Michelson, Andrew L. Frelinger, Jane E. Freedman, Herbert B. Hechtman, Raymond J. Connolly and Matthew D. Linden and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

M.R. BARNARD

30 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M.R. BARNARD United States	21	837	837	320	312	294	30	2.2k
R L Kinlough-Rathbone Canada	33	1.1k 1.3×	1.2k 1.4×	569 1.8×	620 2.0×	182 0.6×	129	3.1k
Stefania Momi Italy	23	466 0.6×	610 0.7×	221 0.7×	249 0.8×	415 1.4×	40	1.9k
Iren B. Kovács United Kingdom	22	446 0.5×	302 0.4×	326 1.0×	189 0.6×	114 0.4×	80	1.3k
Giuseppe Guglielmini Italy	22	454 0.5×	376 0.4×	175 0.5×	101 0.3×	153 0.5×	50	1.5k
H G Eichler Austria	26	304 0.4×	286 0.3×	202 0.6×	151 0.5×	401 1.4×	49	1.8k
H. James Day United States	21	377 0.5×	818 1.0×	228 0.7×	465 1.5×	185 0.6×	49	1.9k
A. J. Hellem Norway	15	528 0.6×	727 0.9×	237 0.7×	369 1.2×	129 0.4×	26	1.7k
Piotr Głuszko Poland	18	275 0.3×	239 0.3×	452 1.4×	118 0.4×	110 0.4×	76	1.3k
Paul C. Armstrong United Kingdom	23	543 0.6×	369 0.4×	219 0.7×	149 0.5×	74 0.3×	50	1.4k
Owen Ca United States	25	249 0.3×	829 1.0×	365 1.1×	314 1.0×	118 0.4×	108	2.2k

Countries citing papers authored by M.R. BARNARD

Since Specialization

Citations

This map shows the geographic impact of M.R. BARNARD's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.R. BARNARD with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.R. BARNARD more than expected).

Fields of papers citing papers by M.R. BARNARD

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.R. BARNARD. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.R. BARNARD. The network helps show where M.R. BARNARD may publish in the future.

Co-authorship network of co-authors of M.R. BARNARD

This figure shows the co-authorship network connecting the top 25 collaborators of M.R. BARNARD. A scholar is included among the top collaborators of M.R. BARNARD based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.R. BARNARD. M.R. BARNARD is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chang, Hung, et al.. (2012). Modified diadenosine tetraphosphates with dual specificity for P2Y1 and P2Y12 are potent antagonists of ADP‐induced platelet activation. Journal of Thrombosis and Haemostasis. 10(12). 2573–2580. 15 indexed citations

Psaila, Bethan, James B. Bussel, Andrew L. Frelinger, et al.. (2011). Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia. Journal of Thrombosis and Haemostasis. 9(11). 2302–2310. 87 indexed citations

Przyklenk, Karin, Andrew L. Frelinger, Matthew D. Linden, et al.. (2009). Targeted inhibition of the serotonin 5HT2A receptor improves coronary patency in an in vivo model of recurrent thrombosis. Journal of Thrombosis and Haemostasis. 8(2). 331–340. 41 indexed citations

Frelinger, Andrew L., Matthew D. Linden, Inge Tarnow, et al.. (2008). Aspirin ‘resistance’: role of pre‐existent platelet reactivity and correlation between tests. Journal of Thrombosis and Haemostasis. 6(12). 2035–2044. 69 indexed citations

Frelinger, Andrew L., Joseph A. Jakubowski, M.R. BARNARD, et al.. (2008). The active metabolite of prasugrel inhibits adenosine diphosphate- and collagen-stimulated platelet procoagulant activities. Journal of Thrombosis and Haemostasis. 6(2). 359–365. 2 indexed citations

Linden, Matthew D., M.I. Furman, Andrew L. Frelinger, et al.. (2007). Indices of platelet activation and the stability of coronary artery disease. Journal of Thrombosis and Haemostasis. 5(4). 761–765. 94 indexed citations

Frelinger, Andrew L., J.A. Jakubowski, M.R. BARNARD, et al.. (2007). The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: Influence of other blood cells, calcium, and aspirin. Journal of Thrombosis and Haemostasis. 98(1). 192–200. 5 indexed citations

Michelson, Alan D., Matthew D. Linden, M.I. Furman, et al.. (2006). Evidence that pre‐existent variability in platelet response to ADP accounts for ‘clopidogrel resistance’. Journal of Thrombosis and Haemostasis. 5(1). 75–81. 70 indexed citations

Linden, Matthew D., Peter Whittaker, Andrew L. Frelinger, et al.. (2006). Preconditioning ischemia attenuates molecular indices of platelet activation‐aggregation. Journal of Thrombosis and Haemostasis. 4(12). 2670–2677. 29 indexed citations

10.

Furman, M.I., Lori A. Krueger, Matthew D. Linden, et al.. (2005). GPIIb–IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary intervention. Journal of Thrombosis and Haemostasis. 3(2). 312–320. 39 indexed citations

11.

Valeri, C. R., Hollace MacGregor, M.R. BARNARD, et al.. (2005). Survival of baboon biotin‐X‐N‐hydroxysuccinimide and ¹¹¹In‐oxine‐labelled autologous fresh and lyophilized reconstituted platelets. Vox Sanguinis. 88(2). 122–129. 21 indexed citations

12.

BARNARD, M.R., Matthew D. Linden, Andrew L. Frelinger, et al.. (2005). Effects of platelet binding on whole blood flow cytometry assays of monocyte and neutrophil procoagulant activity. Journal of Thrombosis and Haemostasis. 3(11). 2563–2570. 66 indexed citations

13.

Valeri, C. R., Hollace MacGregor, M.R. BARNARD, et al.. (2004). In vitro testing of fresh and lyophilized reconstituted human and baboon platelets. Transfusion. 44(10). 1505–1512. 16 indexed citations

14.

Sun, Carol, Angela L. Bergeron, Manu Pillai, et al.. (2003). Platelet FcγRIIA HIS131ARG polymorphism and platelet function: antibodies to platelet-bound fibrinogen induce platelet activation. Journal of Thrombosis and Haemostasis. 1(2). 355–362. 15 indexed citations

15.

BARNARD, M.R., Hollace MacGregor, Richard W. Mercier, et al.. (1999). Platelet surface p‐selectin, platelet–granulocyte heterotypic aggregates, and plasma‐soluble p‐selectin during plateletpheresis. Transfusion. 39(7). 735–741. 17 indexed citations

16.

Freedman, Jane E., et al.. (1997). Nitric oxide released from activated platelets inhibits platelet recruitment.. Journal of Clinical Investigation. 100(2). 350–356. 304 indexed citations

17.

Freedman, Jane E., Joseph Loscalzo, Stephen Benoit, et al.. (1996). Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis.. Journal of Clinical Investigation. 97(4). 979–987. 123 indexed citations

18.

Michelson, Alan D., Stephen Benoit, M.I. Furman, et al.. (1996). Effects of nitric oxide/EDRF on platelet surface glycoproteins. American Journal of Physiology-Heart and Circulatory Physiology. 270(5). H1640–H1648. 73 indexed citations

19.

Wynick, David, W. A. Ratcliffe, D. A. Heath, et al.. (1990). Treatment of a malignant pancreatic endocrine tumour secreting parathyroid hormone related protein.. BMJ. 300(6735). 1314–1315. 36 indexed citations

20.

Michelson, Alan D., et al.. (1988). Platelet storage results in a redistribution of glycoprotein Ib molecules. Evidence for a large intraplatelet pool of glycoprotein Ib.. Journal of Clinical Investigation. 81(6). 1734–1740. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact